+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) - Global Forecast to 2026

  • ID: 5116505
  • Report
  • November 2021
  • Region: Global
  • 201 Pages
  • Markets and Markets

FEATURED COMPANIES

  • Agilent Technologies
  • Caribou Biosciences
  • Crispr Therapeutics Ag
  • Intellia Therapeutics
  • New England Biolabs
  • Precision Biosciences

The global genome editing/genome engineering market is expected to reach USD 11.7 billion by 2026 from USD 5.1 billion in 2021, at a CAGR of 18.2% during the forecast period. The growth of the genome editing/genome engineering market is expected to be driven by the rise in government funding and growth in the number of genomics projects, increased application areas of genomics, and the introduction of CRISPR-Cas9 for genome engineering. 






“The services segment accounted for the highest growth rate in the genome editing/genome engineering market, by product & service, during the forecast period”

In 2020, the services segment accounted for the highest growth rate. The genomic editing/genome engineering services market is segmented into sequencing services; data analysis; bioinformatics services; and other services, such as informatics, clean up, gene expression, and DNA synthesis services. Most companies in the services sector offer all these services. Although the services segment represents a major part of the market, some end users have in-house sequencing and bioinformatics capabilities. Service providers possess highly advanced and multiple sequencing platforms and make use of high-quality consumables/kits. They also have multiple sequencing platforms, which enables these service providers to choose the most appropriate system to solve the scientific challenges of their customers and promptly deliver high-quality sequencing at a low cost.


“The CRISPR segment accounted for the largest share of the application segment, by technology, in the genome editing/genome engineering”

In 2020, the CRISPR technology accounted for the largest share. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a revolutionary tool used to edit genes in a way that resembles traditional GMO techniques. The use of the Cas9 enzymes differentiates CRISPR from other forms of genetic modification. The ease of use associated with CRISPR technology gives it a significant advantage over ZFN and TALEN, especially in generating a large set of vectors to target numerous sites or even genome-wide libraries. Another potential advantage of CRISPR is its ability to use multiple guide RNA parallelly to target multiple sites simultaneously in the same cell. This makes it easier to mutate multiple genes at once or engineer precise deletions in a genomic region.


“Asia Pacific: The fastest-growing region in the genome editing/genome engineering market”

The genome editing/genome engineering market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). Increasing government support, and developing R&D infrastructure Increasing investments in research and rising number of applications of gene synthesis for genetic engineering of cells and tissues of organisms are the major factors fueling the growth of the genome editing/genome engineering market in the Asia Pacific region.


The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side 30%
  • By Designation: C-level - 55%, D-level - 20%, and Others - 25%
  • By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

List of Companies Profiled in the Report: 

  • Thermo Fisher Scientific (US)
  • Merck KGaA (Germany)
  • GenScript China)
  • Sangamo Therapeutics (US)
  • Lonza (Switzerland)
  • Editas medicine (US)
  • CRISPR Therapeutics
  • Tecan Life sciences (Switzerland)
  • Precision biosciences (US)
  • Agilent technologies (Switzerland)
  • PerkinElmer (US)
  • Cellectis SA (France)
  • Intellia Therapeutics (US)
  • Bluebird Bio (US)
  • Regeneron Pharmaceuticals (US)
  • Synthego (US)
  • Vigene Biosciences (US)
  • Beam Therapeutics (US)
  • Integrated DNA Technologies (US)
  • New England Biolabs (US)
  • Origene Technologies (US)
  • Transposagen Biopharmaceuticals (US)
  • Creative Biogene (US)
  • Recombinetics (US)
  • Caribou Biosciences (US)

Research Coverage:

This report provides a detailed picture of the genome editing/genome engineering market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.


Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genome editing/genome engineering market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.


Frequently Asked Questions about the Global Genome Editing-Genome Engineering Market

What is the estimated value of the Global Genome Editing-Genome Engineering Market?

The Global Genome Editing-Genome Engineering Market was estimated to be valued at $5.1 Billion in 2021.

What is the growth rate of the Global Genome Editing-Genome Engineering Market?

The growth rate of the Global Genome Editing-Genome Engineering Market is 18.2%, with an estimated value of $11.7 Billion by 2026.

What is the forecasted size of the Global Genome Editing-Genome Engineering Market?

The Global Genome Editing-Genome Engineering Market is estimated to be worth $11.7 Billion by 2026.

Who are the key companies in the Global Genome Editing-Genome Engineering Market?

Key companies in the Global Genome Editing-Genome Engineering Market include Agilent Technologies, Beam Therapeutics, Bluebird Bio Inc., Caribou Biosciences, Cellectis S.A, Creative Biogene, Crispr Therapeutics Ag, Editas Medicine and Integrated Dna Technologies.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agilent Technologies
  • Caribou Biosciences
  • Crispr Therapeutics Ag
  • Intellia Therapeutics
  • New England Biolabs
  • Precision Biosciences

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary of Changes


2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 2 Breakdown of Primaries: Genome Editing/Genome Engineering Market
2.2 Market Estimation Methodology
Figure 3 Genome Editing/Genome Engineering Market Size Estimation (Supply-Side Analysis), 2020
Figure 4 Market Size Estimation: Approach 1 (Company Revenue Analysis-Based Estimation), 2020
2.2.1 Insights from Primary Experts
Figure 5 Market Size Validation from Primary Sources
2.3 Market Growth Rate Projections
Figure 6 Genome Editing/Genome Engineering Market (Supply-Side): CAGR Projections
Figure 7 Genome Editing/Genome Engineering Market (Demand-Side): Growth Analysis of Demand-Side Drivers
2.4 Data Triangulation
Figure 8 Data Triangulation Methodology
2.5 Research Assumptions
2.5.1 COVID-19 Specific Assumptions
2.6 Risk Analysis


3 Executive Summary
Figure 9 Genome Editing/Genome Engineering Market, by Product & Service, 2021 Vs. 2026 (USD Million)
Figure 10 Genome Editing/Genome Engineering Market, by Technology 2021 Vs. 2026 (USD Million)
Figure 11 Genome Editing/Genome Engineering, by Application, 2021 Vs. 2026 (USD Million)
Figure 12 Genome Editing/Genome Engineering Market, by End-user 2021 Vs. 2026 (USD Million)
Figure 13 Geographical Snapshot: Genome Editing/Genome Engineering Market


4 Premium Insights
4.1 Genome Editing/Genome Engineering Market Overview
Figure 14 Growing Investments in Genomics Research to Drive Market Growth
4.2 North America: Genome Editing/Genome Engineering Share, by Product & Service and Country (2020)
Figure 15 Reagents & Consumables Segment Accounted for the Largest Share of the Genome Editing/Genome Engineering Market in North America in 2020
4.3 Genome Editing/Genome Engineering Share, by Technology (2020)
Figure 16 the Crispr Segment Accounted for the Largest Share in the Genome Editing/Genome Engineering Market in 2020
4.4 Genome Editing/Genome Engineering Market, by Application, 2021 Vs. 2026 (USD Million)
Figure 17 the Cell Line Engineering Segment Expected to Dominate the Applications Market in 2026
4.5 Genome Editing/Genome Engineering Market Share, by End-user, 2020
Figure 18 the Pharmaceutical Companies Segment Accounted for the Largest Market Share in 2020
4.6 Genome Editing/Genome Engineering Market: Geographic Growth Opportunities
Figure 19 Asia-Pacific to Register the Highest Growth in the Genome Editing/Genome Engineering Market from 2021 to 2026


5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 20 Genome Editing/Genome Engineering Market: Drivers, Restraints, Opportunities, and Challenge
Table 1 Genome Editing/Genome Engineering Market: Impact Analysis
5.2.1 Drivers
5.2.1.1 Rise in Government Funding and Growth in the Number of Genomics Projects
5.2.1.2 Increased Application Areas of Genomics
5.2.1.3 Introduction of Crispr-Cas9
5.2.2 Restraints
5.2.2.1 Off-Target Effects of Crispr Technology
5.2.3 Opportunities
5.2.3.1 Extensive Use of Genome Editing in Personalized Medicine
5.2.3.2 High Growth Prospects for the Market in Emerging Countries
5.2.4 Challenges
5.2.4.1 High Equipment Costs
5.3 Ranges/Scenarios
Figure 21 Spectrum of Scenarios Based on the Impact of Uncertainties on the Growth of the Genome Editing/Genome Engineering Market
5.4 Impact of COVID-19 Outbreak on the Genome Editing/Genome Engineering Market
Figure 22 Genome Editing/Genome Engineering Scenario with and Without COVID-19 Impact. 2019-2021
5.5 Trends/Disruptions Impacting Businesses of Customers
5.6 Value Chain Analysis
Figure 23 Value Chain Analysis of the Genome Editing/Genome Engineering Market: Research and Manufacturing Phase Contributes Maximum Value
5.7 Technological Analysis
5.8 Patent Analysis
Figure 24 Patent Applications for Genetic Engineering Market, January 2011-October 2021
Table 2 Indicative List of Patents in the Genome Editing/Genome Engineering Market
5.9 Ecosystem Analysis of the Genome Editing/Genome Engineering Market
Figure 25 Ecosystem Analysis of the Genome Editing/Genome Engineering Market
Table 3 Supply Chain Ecosystem
5.10 Porter's Five Forces Analysis
Table 4 Genome Editing/ Genome Engineering Market: Porter's Five Forces Analysis
5.10.1 Threat of New Entrants
5.10.2 Threat of Substitutes
5.10.3 Bargaining Power of Suppliers
5.10.4 Bargaining Power of Buyers
5.10.5 Competitive Rivalry Among Existing Players
5.11 Regulatory Analysis
5.11.1 Regulations for Products Developed Using Genome Editing/Genome Engineering Technology
5.11.1.1 US
Table 5 Regulations for Products Developed Using Genome Editing/Genome Engineering Techniques
5.11.1.2 China


6 Genome Editing/Genome Engineering Market, by Product & Service
6.1 Introduction
Table 6 Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
6.2 Reagents & Consumables
6.2.1 Reagents & Consumables Hold the Largest Market Share
Table 7 Genome Editing/Genome Engineering Reagents & Consumables Market, by Region, 2019-2026 (USD Million)
Table 8 North America: Genome Editing/Genome Engineering Reagents & Consumables Market, by Country, 2019-2026 (USD Million)
Table 9 Europe: Genome Editing/Genome Engineering Reagents & Consumables Market, by Country, 2019-2026 (USD Million)
Table 10 APAC: Genome Editing/Genome Engineering Reagents & Consumables Market, by Country, 2019-2026 (USD Million)
Table 11 Latam: Genome Editing/Genome Engineering Reagents & Consumables Market, by Region, 2019-2026 (USD Million)
6.3 Software & Systems
6.3.1 Rising Application of Genome Editing/Sequencing to Increase the Demand for Systems and Software
Table 12 Genome Editing/Genome Engineering Software & Systems Market, by Region, 2019-2026 (USD Million)
Table 13 North America: Genome Editing/Genome Engineering Software & Systems Market, by Country, 2019-2026 (USD Million)
Table 14 Europe: Genome Editing/Genome Engineering Software & Systems Market, by Country, 2019-2026 (USD Million)
Table 15 APAC: Genome Editing/Genome Engineering Software & Systems Market, by Country, 2019-2026 (USD Million)
Table 16 Latam: Genome Editing/Genome Engineering Software & Systems Market, by Region, 2019-2026 (USD Million)
6.4 Services
6.4.1 Wide Application of Editing/Genome Engineering Services to Increase Market Growth
Table 17 Genome Editing/Genome Engineering Services Market, by Region, 2019-2026 (USD Million)
Table 18 North America: Genome Editing/Genome Engineering Services Market, by Country, 2019-2026 (USD Million)
Table 19 Europe: Genome Editing/Genome Engineering Services Market, by Country, 2019-2026 (USD Million)
Table 20 APAC: Genome Editing/Genome Engineering Services Market, by Country, 2019-2026 (USD Million)
Table 21 Latam: Genome Editing/Genome Engineering Services Market, by Region, 2019-2026 (USD Million)


7 Genome Editing/Genome Engineering Market, by Technology
7.1 Introduction
Table 22 Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
7.2 Crispr
7.2.1 Ease of Use Gives Crispr An Advantage Over Other Technologies
Table 23 Genome Editing/Genome Engineering Market for Crispr, by Region, 2019-2026 (USD Million)
Table 24 North America: Genome Editing/Genome Engineering Market for Crispr, by Country, 2019-2026 (USD Million)
Table 25 Europe: Genome Editing/Genome Engineering Market for Crispr, by Country, 2019-2026 (USD Million)
Table 26 APAC: Genome Editing/Genome Engineering Market for Crispr, by Country, 2019-2026 (USD Million)
Table 27 Latam: Genome Editing/Genome Engineering Market for Crispr, by Region, 2019-2026 (USD Million)
7.3 Talen
7.3.1 Quick Modifications in the Genome Sequence Are Possible with Talen
Table 28 Genome Editing/Genome Engineering Market for Talen, by Region, 2019-2026 (USD Million)
Table 29 North America: Genome Editing/Genome Engineering Market for Talen, by Country, 2019-2026 (USD Million)
Table 30 Europe: Genome Editing/Genome Engineering Market for Talen, by Country, 2019-2026 (USD Million)
Table 31 APAC: Genome Editing/Genome Engineering Market for Talen, by Country, 2019-2026 (USD Million)
Table 32 Latam: Genome Editing/Genome Engineering Market for Talen, by Region, 2019-2026 (USD Million)
7.4 Zfn
7.4.1 Eukaryote Cell Studies Done by Zfn to Drive Market Growth
Table 33 Genome Editing/Genome Engineering Market for Zfn, by Region, 2019-2026 (USD Million)
Table 34 North America: Genome Editing/Genome Engineering Market for Zfn, by Country, 2018-2025 (USD Million)
Table 35 Europe: Genome Editing/Genome Engineering Market for Zfn, by Country, 2019-2026 (USD Million)
Table 36 APAC: Genome Editing/Genome Engineering Market for Zfn, by Country, 2019-2026 (USD Million)
Table 37 Latam: Genome Editing/Genome Engineering Market for Zfn, by Region, 2019-2026 (USD Million)
7.5 Antisense
7.5.1 Increased Application in Engineering Human Cells for Disease Study to Drive Market Growth
Table 38 Genome Editing/Genome Engineering Market for Antisense, by Region, 2019-2026 (USD Million)
Table 39 North America: Genome Editing/Genome Engineering Market for Antisense, by Country, 2019-2026 (USD Million)
Table 40 Europe: Genome Editing/Genome Engineering Market for Antisense, by Country, 2019-2026 (USD Million)
Table 41 APAC: Genome Editing/Genome Engineering Market for Antisense, by Country, 2019-2026 (USD Million)
Table 42 Latam: Genome Editing/Genome Engineering Market for Antisense, by Region, 2019-2026 (USD Million)
7.6 Other Technologies
Table 43 Genome Editing/Genome Engineering Market for Other Technologies, by Region, 2019-2026 (USD Million)
Table 44 North America: Genome Editing/Genome Engineering Market for Other Technologies, by Country, 2019-2026 (USD Million)
Table 45 Europe: Genome Editing/Genome Engineering Market for Other Technologies, by Country, 2019-2026 (USD Million)
Table 46 APAC: Genome Editing/Genome Engineering Market for Other Technologies, by Country, 2019-2026 (USD Million)
Table 47 Latam: Genome Editing/Genome Engineering Market for Other Technologies, by Region, 2019-2026 (USD Million)


8 Genome Editing/Genome Engineering Market, by Application
8.1 Introduction
Table 48 Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
8.2 Cell Line Engineering
8.2.1 Increasing Research Applications of Cell Line Engineering to Promote Market Growth
Table 49 Genome Editing/Genome Engineering Market for Cell Line Engineering, by Region, 2019-2026 (USD Million)
Table 50 North America: Genome Editing/Genome Engineering Market for Cell Line Engineering, by Country, 2019-2026 (USD Million)
Table 51 Europe: Genome Editing/Genome Engineering Market for Cell Line Engineering, by Country, 2019-2026 (USD Million)
Table 52 APAC: Genome Editing/Genome Engineering Market for Cell Line Engineering, by Country, 2019-2026 (USD Million)
Table 53 Latam: Genome Editing/Genome Engineering Market for Cell Line Engineering, by Region, 2019-2026 (USD Million)
8.3 Genetic Engineering
8.3.1 Animal Genetic Engineering
8.3.1.1 Use of Animal Simulation Models in Research to Increase the Demand for Genome Editing
8.3.2 Plant Genetic Engineering
8.3.2.1 Growing Attention on Gm Crops Will Drive Demand for Genetic Engineering in Crops
Table 54 Genome Editing/Genome Engineering Market for Genetic Engineering, by Region, 2019-2026 (USD Million)
Table 55 North America: Genome Editing/Genome Engineering Market for Genetic Engineering, by Country, 2019-2026 (USD Million)
Table 56 Europe: Genome Editing/Genome Engineering Market for Genetic Engineering, by Country, 2019-2026 (USD Million)
Table 57 APAC: Genome Editing/Genome Engineering Market for Genetic Engineering, by Country, 2019-2026 (USD Million)
Table 58 Latam: Genome Editing/Genome Engineering Market for Genetic Engineering, by Region, 2019-2026 (USD Million)
8.4 Diagnostic Applications
8.4.1 the Growing Number of Applications in Diagnostics Will Favor Market Growth
Table 59 Genome Editing/Genome Engineering Market for Diagnostic Applications, by Region, 2019-2026 (USD Million)
Table 60 North America: Genome Editing/Genome Engineering Market for Diagnostic Applications, by Country, 2019-2026 (USD Million)
Table 61 Europe: Genome Editing/Genome Engineering Market for Diagnostic Applications, by Country, 2019-2026 (USD Million)
Table 62 APAC: Genome Editing/Genome Engineering Market for Diagnostic Applications, by Country, 2019-2026 (USD Million)
Table 63 Latam: Genome Editing/Genome Engineering Market for Diagnostic Applications, by Region, 2019-2026 (USD Million)
8.5 Drug Discovery & Development
8.5.1 Growing Research and Applications in Drug Discovery & Development to Drive Market Growth
Table 64 Genome Editing/Genome Engineering Market for Drug Discovery & Development, by Region, 2019-2026 (USD Million)
Table 65 North America: Genome Editing/Genome Engineering Market for Drug Discovery & Development, by Country, 2019-2026 (USD Million)
Table 66 Europe: Genome Editing/Genome Engineering Market for Drug Discovery & Development, by Country, 2019-2026 (USD Million)
Table 67 APAC: Genome Editing/Genome Engineering Market for Drug Discovery & Development, by Country, 2019-2026 (USD Million)
Table 68 Latam: Genome Editing/Genome Engineering Market for Drug Discovery & Development, by Region, 2019-2026 (USD Million)
8.6 Other Applications
Table 69 Genome Editing/Genome Engineering Market for Other Applications, by Region, 2019-2026 (USD Million)
Table 70 North America: Genome Editing/Genome Engineering Market for Other Applications, by Country, 2019-2026 (USD Million)
Table 71 Europe: Genome Editing/Genome Engineering Market for Other Applications, by Country, 2019-2026 (USD Million)
Table 72 APAC: Genome Editing/Genome Engineering Market for Other Applications, by Country, 2019-2026 (USD Million)
Table 73 Latam: Genome Editing/Genome Engineering Market for Other Applications, by Region, 2019-2026 (USD Million)


9 Genome Editing/ Genome Engineering Market, by End-user
9.1 Introduction
Table 74 Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
9.2 Pharmaceutical Companies
9.2.1 Crispr Technologies Are Used by Pharmaceutical Companies for Applications in Gene Therapies
Table 75 Genome Editing/Genome Engineering Market for Pharmaceutical Companies, by Region, 2019-2026 (USD Million)
Table 76 North America: Genome Editing/Genome Engineering Market for Pharmaceutical Companies, by Country, 2019-2026 (USD Million)
Table 77 Europe: Genome Editing/Genome Engineering Market for Pharmaceutical Companies, by Country, 2019-2026 (USD Million)
Table 78 APAC: Genome Editing/Genome Engineering Market for Pharmaceutical Companies, by Country, 2019-2026 (USD Million)
Table 79 Latam: Genome Editing/Genome Engineering Market for Pharmaceutical Companies, by Region, 2019-2026 (USD Million)
9.3 Biotechnology Companies
9.3.1 Increasing Importance of Biomarkers to Drive Demand for Market Products in Biotech Companies
Table 80 Genome Editing/Genome Engineering Market for Biotechnology Companies, by Region, 2019-2026 (USD Million)
Table 81 North America: Genome Editing/Genome Engineering Market for Biotechnology Companies, by Country, 2019-2026 (USD Million)
Table 82 Europe: Genome Editing/Genome Engineering Market for Biotechnology Companies, by Country, 2019-2026 (USD Million)
Table 83 APAC: Genome Editing/Genome Engineering Market for Biotechnology Companies, by Country, 2019-2026 (USD Million)
Table 84 Latam: Genome Editing/Genome Engineering Market for Biotechnology Companies, by Region, 2019-2026 (USD Million)
9.4 Academic & Government Research Institutes
9.4.1 Trend of Collaborative Research Will Support Market Growth
Table 85 Genome Editing/Genome Engineering Market for Academic & Government Research Institutes, by Region, 2019-2026 (USD Million)
Table 86 North America: Genome Editing/Genome Engineering Market for Academic & Government Research Institutes, by Country, 2019-2026 (USD Million)
Table 87 Europe: Genome Editing/Genome Engineering Market for Academic & Government Research Institutes, by Country, 2019-2026 (USD Million)
Table 88 APAC: Genome Editing/Genome Engineering Market for Academic & Government Research Institutes, by Country, 2019-2026 (USD Million)
Table 89 Latam: Genome Editing/Genome Engineering Market for Academic & Government Research Institutes, by Region, 2019-2026 (USD Million)


10 Genome Editing/Genome Engineering Market, by Region
10.1 Introduction
Figure 26 Genome Editing/Genome Engineering Market, by Region
Table 90 Genome Editing/Genome Engineering Market, by Region, 2019-2026 (USD Million)
10.2 North America
Figure 27 North America: Genome Editing/Genome Engineering Market Snapshot
Table 91 North America: Genome Editing/Genome Engineering Market, by Country, 2019-2026 (USD Million)
Table 92 North America: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 93 North America: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 94 North America: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 95 North America: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.2.1 US
10.2.1.1 the US Dominates the North American Market
Table 96 US: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 97 US: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 98 US: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 99 US: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.2.2 Canada
10.2.2.1 Availability of Research Funding in Canada Drives the Market Growth
Table 100 Canada: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 101 Canada: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 102 Canada: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 103 Canada: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.3 Europe
Table 104 Europe: Genome Editing/Genome Engineering Market, by Country, 2019-2026 (USD Million)
Table 105 Europe: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 106 Europe: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 107 Europe: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 108 Europe: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.3.1 Germany
10.3.1.1 Strong Academic Base and Rising Awareness Are Key Growth Drivers in Germany
Table 109 Germany: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 110 Germany: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 111 Germany: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 112 Germany: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 USD Million)
10.3.2 UK
10.3.2.1 the UK is the Largest Market for Genome Engineering in Europe
Table 113 Uk: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 114 Uk: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 115 Uk: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 116 Uk: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.3.3 France
10.3.3.1 Government Funding for Genomics and Rising Investments into Research Show Potential for Market Growth
Table 117 France: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 118 France: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 119 France: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 120 France: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.3.4 Italy
10.3.4.1 Increasing Collaborations Are Driving Genomic Medicine Research, Thus, Boosting the Gene Editing Market in Italy
Table 121 Italy: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 122 Italy: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 123 Italy: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 124 Italy: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 USD Million)
10.3.5 Spain
10.3.5.1 Proactive Research Funding by the Government to Boost the Market Growth
Table 125 Spain: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 126 Spain: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 127 Spain: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 128 Spain: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 USD Million)
10.3.6 Rest of Europe
Table 129 RoE: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 130 RoE: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 131 RoE: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 132 RoE: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.4 Asia-Pacific
Figure 28 APAC: Genome Editing/Genome Engineering Market Snapshot
Table 133 APAC: Genome Editing/Genome Engineering Market, by Country, 2019-2026 (USD Million)
Table 134 APAC: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 135 APAC: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 136 APAC: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 137 APAC: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.4.1 China
10.4.1.1 China to Hold the Largest Share of the Market in the Asia-Pacific
Table 138 China: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 139 China: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 140 China: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 141 China: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.4.2 Japan
10.4.2.1 Focus on Cancer Research Showcases Favorable Scenarios for the Market in Japan
Table 142 Japan: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 143 Japan: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 144 Japan: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 145 Japan: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.4.3 India
10.4.3.1 a Growing Number of Startups and Government Support Indicates Growth Potential
Table 146 India: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 147 India: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 148 India: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 149 India: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.4.4 Roapac
10.4.4.1 the Growth of the Market in the Roapac is Attributed to Rising Genomic Research
Table 150 Roapac: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 151 Roapac: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 152 Roapac: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 153 Roapac: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.5 Rest of the World
10.5.1 Latam
10.5.1.1 the Growth of the Market in the Latam is Attributed to Rising Research in Genetically Modified Crops
Table 154 Latam: Genome Editing/Genome Engineering Market, by Region, 2019-2026 (USD Million)
Table 155 Latam: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 156 Latam: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 157 Latam: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 158 Latam: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.5.1.2 Brazil
10.5.1.2.1 the Rising Number of Workshops and Conferences Are Increasing Awareness, Thus, Promoting Genome Editing Advancements
Table 159 Brazil: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 160 Brazil: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 161 Brazil: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 162 Brazil: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.5.1.3 Rest of Latam
10.5.1.3.1 Latin America is An Attractive Market for Genomics
Table 163 Rest of Latam: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 164 Rest of Latam: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 165 Rest of Latam: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 166 Rest of Latam: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)
10.5.2 Middle East & Africa
10.5.2.1 the Rising Prevalence of Genomic Disorders in the Middle East and the Adoption of Genetic Testing Are Driving Market Growth
Table 167 Mea: Genome Editing/Genome Engineering Market, by Product & Service, 2019-2026 (USD Million)
Table 168 Mea: Genome Editing/Genome Engineering Market, by Technology, 2019-2026 (USD Million)
Table 169 Mea: Genome Editing/Genome Engineering Market, by Application, 2019-2026 (USD Million)
Table 170 Mea: Genome Editing/Genome Engineering Market, by End-user, 2019-2026 (USD Million)


11 Competitive Landscape
11.1 Overview
11.2 Key Players Strategies/Right to Win
Figure 29 Key Players Strategies in the Genome Editing/Genome Engineering Market, 2019- 2021
11.3 Market Share Analysis
Figure 30 Genome Editing/Genome Engineering Market Player Ranking, 2020
11.4 Revenue Share Analysis of Top Market Players
Figure 31 Top Market Players Dominated the Genome Editing/Genome Engineering Market in the Last Three Years
11.5 Company Evaluation Quadrant
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive
11.5.4 Emerging Companies
Figure 32 Genome Editing/Genome Engineering Market: Company Evaluation Quadrant, 2020
11.6 Company Evaluation Quadrant: Start-Ups/Smes
11.6.1 Progressive Companies
11.6.2 Starting Blocks
11.6.3 Responsive Companies
11.6.4 Dynamic Companies
Figure 33 Genome Editing/Genome Engineering Market: Company Evaluation Quadrant for Start-Ups/Smes, 2020
11.7 Company Product Footprint
Table 171 Product Portfolio Analysis: Genome Editing/Genome Engineering Market (2020)
11.8 Company Geographic Footprint
Table 172 Geographic Revenue Mix: Genome Editing/Genome Engineering Market (2020)
11.9 Competitive Scenario
11.9.1 Service/ Product Launches
11.9.2 Deals
11.9.3 Other Developments


12 Company Profiles
12.1 Key Companies
(Business Overview, Products & Services Offered, Recent Developments, Analyst's View, Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats)*
12.1.1 Thermo Fisher Scientific
Table 173 Thermo Fisher Scientific: Business Overview
Figure 34 Thermo Fisher Scientific: Company Snapshot (2020)
12.1.2 Merck Kgaa
Table 174 Merck Kgaa: Business Overview
Figure 35 Merck Kgaa: Company Snapshot (2020)
12.1.3 Genscript
Table 175 Genscript: Business Overview
Figure 36 Genscript: Company Snapshot (2020)
12.1.4 Sangamo Therapeutics
Table 176 Sangamo Therapeutics: Business Overview
Figure 37 Sangamo Therapeutics: Company Snapshot (2020)
12.1.5 Lonza
Table 177 Lonza: Business Overview
Figure 38 Lonza: Company Snapshot (2020)
12.1.6 Editas Medicine
Table 178 Editas Medicine: Business Overview
Figure 39 Editas Medicine: Company Snapshot (2020)
12.1.7 Crispr Therapeutics Ag
Table 179 Crispr Therapeutics Ag: Business Overview
Figure 40 Crispr Therapeutics Ag: Company Snapshot (2020)
12.1.8 Tecan Life Sciences
Table 180 Tecan Lifesciences: Business Overview
Figure 41 Tecan Lifesciences: Company Snapshot (2020)
12.1.9 Precision Biosciences
Table 181 Precision Biosciences: Business Overview
Figure 42 Precision Biosciences: Company Snapshot (2020)
12.1.10 Agilent Technologies
Table 182 Agilent Technologies: Business Overview
Figure 43 Agilent Technologies: Company Snapshot (2020)
12.1.11 Perkinelmer
Table 183 Perkinelmer: Business Overview
Figure 44 Perkinelmer: Company Snapshot (2020)
12.1.12 Cellectis S.A
Table 184 Cellectis S.A: Business Overview
Figure 45 Cellectis S.A: Company Snapshot (2020)
12.1.13 Intellia Therapeutics
Table 185 Intellia Therapeutics: Business Overview
Figure 46 Intellia Therapeutics: Company Snapshot (2020)
12.1.14 Bluebird Bio Inc.
Table 186 Bluebird Bio: Business Overview
Figure 47 Bluebird Bio: Company Snapshot (2020)
12.1.15 Regeneron Pharmaceuticals Inc.
Table 187 Regeneron Pharmaceuticals: Business Overview
Figure 48 Regeneron Pharmaceuticals: Company Snapshot (2020)
12.2 Other Players
12.2.1 Synthego Corporation
12.2.2 Vigene Biosciences
12.2.3 Beam Therapeutics
12.2.4 Integrated Dna Technologies
12.2.5 New England Biolabs
12.2.6 Origene Technologies
12.2.7 Transposagen Biopharmaceuticals [Hera Biolabs]
12.2.8 Creative Biogene
12.2.9 Recombinetics
12.2.10 Caribou Biosciences
*Details on Business Overview, Products & Services Offered, Recent Developments, Analyst's View, Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats Might Not be Captured in Case of Unlisted Companies.


13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: The Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details


Note: Product cover images may vary from those shown
  • Agilent Technologies
  • Beam Therapeutics
  • Bluebird Bio Inc.
  • Caribou Biosciences
  • Cellectis S.A
  • Creative Biogene
  • Crispr Therapeutics Ag
  • Editas Medicine
  • Genscript
  • Integrated Dna Technologies
  • Intellia Therapeutics
  • Lonza
  • Merck Kgaa
  • New England Biolabs
  • Origene Technologies
  • Perkinelmer
  • Precision Biosciences
  • Recombinetics
  • Regeneron Pharmaceuticals Inc.
  • Sangamo Therapeutics
  • Synthego Corporation
  • Tecan Life Sciences
  • Thermo Fisher Scientific
  • Transposagen Biopharmaceuticals [Hera Biolabs]
  • Vigene Biosciences
Note: Product cover images may vary from those shown

Loading
LOADING...